Pancreatic Cancer Research

ResearcherMayo ClinicActive in the last 2 years

Santanu Bhattacharya

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3579-4317; OpenAlex author ID A5101527701, A5130068954. Sources: OpenAlex.

Their work

Papers
12 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
15
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 2 papers · 2025: 2 papers · 2026: 3 papers

Papers 12

  1. Tumor Treating Fields (TTFields) potentiate cisplatin efficacy and remodel the transcriptional landscape in preclinical models of pancreatic ductal adenocarcin… Co-author DOI 10.1016/j.canlet.2026.218651↗
  2. Amphiphilic Glycopolymer Nanoparticles for pH-Responsive Paclitaxel Delivery and Enhanced Efficacy in Pancreatic Ductal Adenocarcinoma Therapy. Co-author DOI 10.1021/acsabm.5c02077↗
  3. Combining Tumor Treating Fields with Immunotherapy in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Therapeutic Synergy. Co-author DOI 10.3390/cells15090845↗
  4. Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Efficacy and Overcomes Chemoresistance in … Co-author DOI 10.1053/j.gastro.2024.09.009↗
  5. Tumor-Treating Fields Alter Nanomechanical Properties of Pancreatic Ductal Adenocarcinoma Cells Co-Cultured with Extracellular Matrix. Last author DOI 10.3390/jfb16050160↗
  6. Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.mtbio.2024.101199↗
  7. Surface Chemistry of Gold Nanoparticles Modulates Cytokines and Nanomechanical Properties in Pancreatic Cancer Cell Lines: A Correlative Study. Last author DOI 10.26502/fjhs.170↗
  8. Nanomechanical Insight of Pancreatic Cancer Cell Membrane during Receptor Mediated Endocytosis of Targeted Gold Nanoparticles. Last author DOI 10.1021/acsabm.0c01443↗
  9. DNA-SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-18-3337↗
  10. Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer. Last author DOI 10.1039/c7nr03172f↗
  11. Pancreatic Cancer-Derived Exosomes Cause Paraneoplastic β-cell Dysfunction. Co-author DOI 10.1158/1078-0432.ccr-14-2022↗
  12. GAIP interacting protein C-terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. Co-author DOI 10.1371/journal.pone.0114409↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Debabrata Mukhopadhyay · 10 shared papers, 2014–2026 · strength 2.11
  2. Hani M. Babiker · 4 shared papers, 2024–2026 · strength 1.15
  3. Hari Krishnareddy Rachamala · 4 shared papers, 2024–2026 · strength 1.14
  4. Krishnendu Pal · 5 shared papers, 2014–2026 · strength 0.89
  5. Tanmay Kulkarni · 3 shared papers, 2021–2025 · strength 0.83
  6. Naga Malleswara Rao Nakka · 3 shared papers, 2024–2026 · strength 0.78
  7. Douaa Albelal · 2 shared papers, 2026 · strength 0.62
  8. Debabrata Mukhopadhyay · 1 shared paper, 2025 · strength 0.30
  9. Suresh T. Chari · 2 shared papers, 2014–2015 · strength 0.08
  10. Thomas C. Smyrk · 1 shared paper, 2015 · strength 0.05
  11. Gunisha Sagar · 1 shared paper, 2015 · strength 0.05
  12. Naureen Javeed · 1 shared paper, 2015 · strength 0.05
  13. Mark Joseph Truty · 1 shared paper, 2015 · strength 0.05
  14. Gloria M. Petersen · 1 shared paper, 2015 · strength 0.05
  15. Mark R Spaller · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.